Neuropeptide FF, pain and analgesia

European Journal of Pharmacology

Volumn 345, Issue 1, 1998, Pages 1-11

  Roumy, Michel ^a   Zajac, Jean Marie ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

Analgesia; Neuropeptide FF; Opioid

Indexed keywords

DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALOXONE; NALTRINDOLE; NEUROPEPTIDE FF; OPIATE ANTAGONIST; OPIATE RECEPTOR; PHENYLALANYLMETHIONYLARGINYLPHENYLALANINAMIDE;

ANALGESIA; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; DRUG TOLERANCE; HUMAN; INTRACEREBRAL DRUG ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRASPINAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; NEUROMODULATION; NOCICEPTION; NONHUMAN; OPIATE ADDICTION; PAIN; PAIN THRESHOLD; PRIORITY JOURNAL; RECEPTOR DENSITY; REVIEW; SOLITARY TRACT NUCLEUS; SPINAL CORD DORSAL HORN;

AMINO ACID SEQUENCE; ANALGESIA; ANIMALS; CATTLE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; NEUROPEPTIDES; OLIGOPEPTIDES; PAIN; RATS;

EID: 0032510551     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01604-X     Document Type: Review

References (85)

1. Aarnisalo A.A., Panula P. Neuropeptide FF-containing efferent projections from the medial hypothalamus of rat: A phaseolus vulgaris leucoagglutinin study. Neuroscience. 65:1995;175-192.
2. Allard M., Geoffre S., Legendre P., Vincent J.D., Simonnet G. Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: A binding study. Brain Res. 500:1989;169-176.
3. Allard M., Theodosis D.T., Rousselot P., Lombard M.C., Simonnet G. Characterization and localization of a putative morphine-modulating peptide, FLFQPQRFamide, in the rat spinal cord: Biochemical and immunocytochemical studies. Neuroscience. 40:1991;81-92.
4. Allard M., Zajac J.-M., Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience. 49:1992;101-116.
5. Allard M., Jordan D., Zajac J.-M., Ries C., Martin D., Monkouanga D., Kopp N., Simonnet G. Autoradiographic localization of receptors for neuropeptide FF, FLFQPQRFamide, in human spinal sensory system. Brain Res. 633:1994;132-137.
6. Altier N., Stewart J. Neuropeptide FF in the VTA blocks the analgesic effects of both intra-VTA morphine and exposure to stress. Brain Res. 758:1997;250-254.
7. Andersen E., Dafny N. Dorsal raphe stimulation reduces responses of parafascicular neurons to noxious stimulation. Pain. 15:1983;323-331.
8. Attila M., Kurkijarvi U., Kivipelto L., Panula P., Ahtee L. The antiopioid peptide, neuropeptide FF, enhances the effects of acute morphine on the cerebral monoamines in rats. Pharmacol. Res. 32:1995;293-298.
9. Bandler R., Shipley M.T. Columnar organization in the midbrain periaqueductal gray: Modules for emotional expression? Trends Neurosci. 17:1994;379-389.
10. Barnard C.S., Dockray G.J. Increases in arterial blood pressure in the rat in response to a new vertebrate neuropeptide, LPLRFamide, and a related molluscan peptide FMRFamide. Regul. Pept. 8:1984;209-215.
11. Burstein R., Protrebic S. Retrograde labeling of neurons in the spinal cord that project directly to the amygdala or the orbital cortex in the rat. J. Comp. Neurol. 335:1993;469-485.
12. Chai S.H., Tang J., Han J. Antiopioid activity of the cardioexcitatory peptide in central modulation of cardiovascular functions. Eur. J. Pharmacol. 130:1986;315-318.
13. Chen J., Zeng S.-L., Rao Z.-R., Shi J.-W. Serotoninergic projections from the midbrain periaqueductal gray and nucleus raphe dorsalis to the nucleus parafascicularis of the thalamus. Brain Res. 584:1992;294-298.
14. Clements J.R., Beitz A.J., Fletcher T.F., Mullett M.A. Immunocytochemical localization of serotonin in the rat periaqueductal gray: A quantitative light and electron microscopic study. J. Comp. Neurol. 236:1985;60-70.
15. ère Réunion de la Société Française de Pharmacologie (Marseilles, France), vol. 17, p. 23.
16. Delort-Laval, S., Allard, M., Rivot J.P., Stinus, L., 1996. Intracerebroventricular administration of NPFF induced antinociceptive effect: Involvement of serotoninergic neurons, neuropharmacological approach. In: Abstracts of the 8th World Congress on Pain, Vancouver, Canada, vol. 102, p. 360.
17. Desprat C., Zajac J.M. Differential modulation of μ- and δ-opioid antinociception by neuropeptide FF receptors in young mice. Neuropeptides. 31:1997;1-7.
18. Devillers J.-P., Labrouche S.A., Castes E., Simonnet G. Glutamate via NMDA receptors promotes the release of NPFF, an anti-opioid peptide, from rat spinal cord slices. Regul. Pept. 54:1994;85-86.
19. Devillers J.-P., Mazarguil H., Allard M., Dickenson A.H., Zajac J.-M., Simonnet G. Characterization of a potent agonist for NPFF receptors: Binding study in rat spinal cord membranes. Neuropharmacology. 33:1994;661-669.
20. 2+ channels. J. Neurochem. 64:1995;1567-1575.
21. Dupouy V., Zajac J.-M. Effects of neuropeptide FF analogs on morphine analgesia in the nucleus raphe dorsalis. Regul. Pept. 59:1995;349-356.
22. 125I ] [D.Tyr1, (NMe)Phe3] NPFF Synapse. 24:1996;282-296.
23. Dupouy V., Zajac J.-M. Neuropeptide FF receptors control morphine-induced analgesia in the parafascicular nucleus and the nucleus raphe dorsalis. Eur. J. Pharmacol. 330:1997;129-137.
24. Dupouy V., Puget A., Eschalier A., Zajac J.-M. Species differences in the localization of neuropeptide FF receptors in rodents and lagomorph brain and spinal cord. Peptides. 17:1996;399-405.
25. Fardin V., Oliveras J.-L., Besson J.-M. A reinvestigation of the analgesic effects induced by stimulation of the periaqueductal gray matter in the rat. I. The production of behavioral side effects together with analgesia. Brain Res. 306:1984;105-123.
26. Gherardi N., Zajac J.-M. Neuropeptide FF receptors of mouse olfactory bulb: Binding properties and stimulation of adenylate cyclase activity. Peptides. 18:1997;577-583.
27. Gicquel S., Mazarguil H., Allard M., Simonnet G., Zajac J.-M. Analogues of F8Famide resistant to degradation, with high affinity and in situ effects. Eur. J. Pharmacol. 222:1992;61-67.
28. Gicquel S., Mazarguil H., Desprat C., Allard M., Devillers J.-P., Simonnet G., Zajac J.-M. Structure-activity study of neuropeptide FF: Contribution of N-terminal regions to affinity and activity. J. Med. Chem. 37:1994;3477-3481.
29. Giesler G.J., Katter J.J.T., Dado R.J. Direct spinal pathways to the limbic system for nociceptive information. Trends Neurosci. 17:1994;244-250.
30. Gouardères C., Sutak M., Zajac J.-M., Jhamandas K. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur. J. Pharmacol. 237:1993;73-81.
31. Gouardères, C., Jhamandas, K., Sutak, M., Zajac, J.-M., 1994. Analogs of neuropeptide FF modulate spinal nociception in the rat. Regul. Pept. Suppl. 1, 113-114.
32. Gouardères C., Jhamandas K., Sutak M., Zajac J.-M. Role of opioid receptors in the spinal antinociceptive effects of neuropeptide FF analogues. Br. J. Pharmacol. 117:1996;493-501.
33. Gouardères C., Kar S., Zajac J.-M. Presence of neuropeptide FF receptors on primary afferent fibres of the rat spinal cord. Neuroscience. 74:1996;21-27.
34. 3]NPFF Brain Res. Bull. 42:1997;231-238.
35. Greenberg M.J., Painter S.D., Doble K.E., Nagle G.T., Price D.A., Lheman H.K. The molluscan neurosecretory peptide FMRFamide: Comparative pharmacology and relationship to the enkephalins. Fed. Proc. 42:1983;82-86.
36. Guzman A., Legendre P., Allard M., Geoffre S., Vincent J.D., Simonnet G. Electrophysiological effects of FLFQPQRFamide, an endogenous brain morphine modulating peptide, on cultured mouse spinal-cord neurons. Neuropeptides. 14:1989;253-261.
37. Herz A., Albus K., Metys J., Schubert P., Teschemacher H.J. On the central sites for the antinociceptive action of morphine and fentanyl. Neuropharmacology. 9:1970;539-551.
38. Jhamandas K., Sutak M., Yang H.-Y.T. Modulation of spinal opioid antinociception by neuropeptide FF-like endogenous peptide. Soc. Neurosci. 22:1996;1313.
39. Kavaliers M. Inhibitory influences of mammalian FMRFamide (Phe-Met-Arg-Phe-amide)-related peptides on nociception and morphine- and stress-induced analgesia in mice. Neurosci. Lett. 115:1990;307-312.
40. Kavaliers M., Innes D. Sex differences in the effects of neuropeptide FF and IgG from neuropeptide FF on morphine- and stress-induced analgesia. Peptides. 13:1992;603-607.
41. 2-related peptides augments morphine- and stress-induced analgesia in mice. Peptides. 10:1989;741-745.
42. Kivipelto L., Panula P. Central neuronal pathways containing FLFQPQRFamide-like (morphine-modulating) peptides in the rat brain. Neuroscience. 41:1991;137-148.
43. Kivipelto L., Panula P. Origin and distribution of neuropeptide-FF-like immunoreactivity in the spinal cord of rats. J. Comp. Neurol. 307:1991;107-119.
44. Kivipelto L., Majane E.A., Yang H.-Y.T., Panula P. Immunohistochemical distribution and partial characterization of FLFQPQRFamide-like peptides in the central nervous system of rats. J. Comp. Neurol. 286:1989;269-287.
45. Kivipelto L., Aarnisalo A., Panula P. Neuropeptide FF is colocalized with catecholamine-synthesizing enzymes in neurons of the nucleus of the solitary tract. Neurosci. Lett. 143:1992;190-194.
46. 2-adrenergic and μ-opioid spinal antinociception by neuropeptide FF. Peptides. 16:1995;973-977.
47. Kontinen V.K., Aarnisalo A.A., Idänpään-Heikkilä J.J., Panula P., Kalso E. Neuropeptide FF in the rat spinal cord during carrageenan inflammation. Peptides. 18:1997;287-292.
48. Lake J.R., Hammond M.V., Shaddox R.C., Hunsicker L.M., Yang H.-Y.T., Malin D.H. IgG from neuropeptide FF antiserum reverses morphine tolerance in the rat. Neurosci. Lett. 132:1991;29-32.
49. Lee C.-H., Wasowicz D.H., Brown R., Majane E.A., Yang H.-Y.T., Panula P. Distribution and characterization of neuropeptide FF-like immunoreactivity in the rat nervous system with a monoclonal antibody. Eur. J. Neurosci. 5:1993;1339-1348.
50. Lombard M.-C., Simonnet G., Zajac J.-M., Besson J.-M., Allard M. Distribution of neuropeptide FF (FLFQPQRFamide) receptors in the adult rat spinal cord: Effects of dorsal rhizotomy and neonatal capsaicin. Neuroscience. 68:1995;1229-1235.
51. 2 with μ and δ opioid antinociception in the rat spinal cord. Neuropeptides. 16:1990;213-218.
52. 2-like peptide in spinal cord of various mammalian species using specific radioimmunoassays. Peptides. 9:1988;1137-1144.
53. 2-like peptide. Brain Res. 494:1989;1-12.
54. Malin D.H., Lake J.R., Fowler D.E., Hammond M.V., Brown S.L., Leyva J.E., Prasco P.E., Dougherty T.M. FMRF-NH2-like mammalian peptide precipitates opiate-withdrawal syndrome in the rat. Peptides. 11:1990;277-280.
55. 2-like mammalian octapeptide: Possible role in opiate dependence and abstinence. Peptides. 11:1990;969-972.
56. Malin D.H., Lake J.R., Jones J.A., Morel J.A., Moon W.D., Corbit B.P., Smith D.A., Claunch A.E., Kacher D., Stevens P.A.L., Webb S. Nitric oxide synthesis inhibition attenuates behavioral actions of neuropeptide FF. Peptides. 17:1996;615-618.
57. Marco N., Stinus L., Allard M., LeMoal M., Simonnet G. Neuropeptide FLFQPQRFamide receptors within the ventral mesencephalon and dopaminergic terminal areas: Localization and functional antiopioid involvement. Neuroscience. 64:1995;1035-1044.
58. Miller K., Lupica C. Neuropeptide FF inhibition of morphine effects in the rat hippocampus. Brain Res. 750:1997;81-86.
59. 2 analogs on intestinal motility and nociception in rats. J. Pharmacol. Exp. Ther. 265:1993;96-102.
60. Moises H.C., Rusin K.I., Macdonald R.L. μ- and κ-opioid receptors selectively reduce the same transient components of high-threshold calcium current in rat dorsal root ganglion sensory neurons. J. Neurosci. 14:1994;5903-59016.
61. Moore R.Y., Halaris A.E., Jones B.E. Serotonin neurons of the midbrain raphe: Ascending projections. J. Comp. Neurol. 180:1978;417-438.
62. Oberling P., Stinus L., LeMoal M., Simonnet G. Biphasic effect on nociception and antiopiate activity of neuropeptide FF (FLFQPQRFamide) in the rat. Peptides. 14:1993;919-924.
63. Panula P., Kivipelto L., Nieminen O., Majane E.A., Yang H.-Y.T. Neuroanatomy of morphine-modulating peptides. Med. Biol. 65:1987;127-135.
64. Panula P., Aarnisalo A.A., Wasowicz K. Neuropeptide FF, a mammalian neuropeptide with multiple functions. Prog. Neurobiol. 48:1996;461-487.
65. Payza K., Yang H.-Y.T. Modulating of neuropeptide FF receptors by guanine nucleotides and cations in membranes of rat brain and spinal cord. J. Neurochem. 60:1993;1894-1899.
66. Perry S.J., Huang E.Y., Cronk D., Bagust J., Sharma R., Walker R.J., Wilson S., Burke J.F. A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett. 409:1997;426-430.
67. Peshanski M., Guilbaud G.G., Gautron M. Posterior intralaminar nuclei in the rat neuronal responses to noxious and non-noxious cutaneous stimuli. Exp. Neurol. 72:1981;226-238.
68. Price D.A., Greenberg M.J. Structure of a molluscan cardioexcitatory neuropeptide. Science. 197:1977;670-671.
69. Przewlocki R., Greenberg H., Przewlocka B. Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci. 53:1993;1-5.
70. 2]-FMRFamide in mice. Neuropeptides. 22:1992;195-203.
71. 2+ channels in rat spinal ganglion neurons. NeuroReport. 7:1996;2979-2981.
72. Reyes-Vazquez C., Qiao J.-T., Dafny N. Nociceptive responses in nucleus parafascicularis thalami are modulated by dorsal raphe stimulation and microiontophoretic application of morphine and serotonin. Brain Res. Bull. 23:1989;405-411.
73. Rothman R.B. A review of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse. 12:1992;129-138.
74. 2+ in mouse spinal ganglion neurons. Eur. J. Pharmacol. 306:1996;291-295.
75. Sakata S., Shima F., Kato M., Fukui M. Effects of thalamic parafascicular stimulation on the periaqueductal gray and adjacent reticular formation neurons. A possible contribution to pain control mechanisms. Brain Res. 451:1988;85-96.
76. Stinus L., Allard M., Gold L., Simonnet G. Change in CNS Neuropeptide FF-like material, pain sensitivity, and opiate dependence following chronic morphine treatment. Peptides. 16:1995;1235-1241.
77. 2-adrenergic antinociception in the rat dorsal horn in vivo. Brain Res. 562:1991;327-328.
78. 2-like immunoreactivity. Proc. Natl. Acad. Sci. USA. 81:1984;5002-5005.
79. Vilim E.S., Ziff E. Cloning of the neuropeptide NPFF and NPAF precursor from bovine, rat, mouse and human. Soc. Neurosci. 21:1995;760.
80. Wasowicz K., Panula P. Distribution of neuropeptide FF in porcine spinal cord in comparison with other neuropeptides and serotonin. J. Comp. Neurol. 346:1994;530-540.
81. Wesche D.L., Frederickson R.C. Diurnal differences in opioid peptide levels correlated with nociceptive sensitivity. Life Sci. 24:1979;1861-1868.
82. Wong T.M., Greenberg M.J., Tse S.Y.H. Cardiovascular effects of intraventricular injection of FMRFamide, met-enkephalin and their common analogs in the rat. Comp. Biochem. Physiol. 81C:1985;175-179.
83. Yang H.-Y.T., Martin B.M. Isolation and characterization of a neuropeptide FF-like peptide from brain and spinal cord of rat. Soc. Neurosci. 21:1995;760.
84. Yang H.-Y.T., Fratta W., Majane E.A., Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of the two brain neuropeptides that modulate the action of morphine. Proc. Natl. Acad. Sci. USA. 82:1985;7757-7761.
85. 2) from rat spinal cord. Brain Res. 592:1992;326-332.